Yabao Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 54.9% in First Quarter of 2023

Yabao Pharmaceutical Group Co.,Ltd. (亚宝药业集团股份有限公司) (600351.SH) reported a net profit of 108.5 million yuan in the first quarter of 2023, up 54.9% year-on-year.

Meanwhile, the company posted 800.5 million yuan in revenue, up 15.3% year-on-year.

At the end of the reporting period, it had 4.2 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 26.1%.